TNF and diabetic neuropathy: COMP-Ang-1, by restoring molecular markers of neuropathy, increasing angiogenesis, and decreasing Cx43 and TNF-ɑ expression in the sciatic nerves of ob/ob mice, showed a new therapeutic approach related to diabetic neuropathy.